Dupilumab Significantly Improves Atopic Dermatitis In Children Aged 6-11 Years: Results From A Phase Iii Trial (Liberty Ad Peds)

BRITISH JOURNAL OF DERMATOLOGY(2020)

引用 0|浏览11
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要